About 1 man in 6 will be diagnosed with prostate cancer during his lifetime. This year, estimates call for more than 200,000 new cases of prostate cancer to be diagnosed. $20+ Million has been invested to date in developing this treatment for prostate cancer
Today we introduce you to a publicly traded company with a novel approach for the treatment of prostate cancer. The science and technology surrounding the company’s product can be summed up in this one statement by the CEO, ““There is ample evidence in the scientific literature that antagonists of Bradykini receptors such as R-954, (IntrakinTM), can be effective in the treatment of prostate cancer by inhibiting tumor cells’ growth and invasiveness. “ …The statistics are alarming and getting worse by day for prostate cancer. The financial losses that a family can experience are astronomical. In fact, the National Cancer Institute came out with a report showing that over $9.9 Billion in economic earnings were lost last year because of prostate cancer. The answers to this devastating disease have shown mediocre results at best with Provenge leading the pack by extending a prostate cancers life by just over 4 months and the next one is Chemo, which extends the life by just over 2 months. The market is ripe for new products and results. Please read on to find out more.
To request a full package on the featured company please fill out the form below
$9.9 Billion in economic earning was lost last year because of prostate cancer
The Opportunity: Prostate cancer is the most common non-skin malignancy in men and is responsible for more deaths than any other cancer, except for lung cancer. The American Cancer Society estimated that about 218,890 new cases of prostate cancer were diagnosed in the United States during 2007. About 1 man in 6 will be diagnosed with prostate cancer during his lifetime, but only 1 man in 34 will die of it. A little over 1.8 million men in the United States are survivors of prostate cancer.
Facts about Prostate Cancer:
- 24,600 men will be diagnosed with prostate cancer this year alone (2010).
- 4,300 men will die of the disease this year.*
- During his lifetime, 1 in 6 men will be diagnosed with the disease.
- Prostate cancer is the most common cancer to afflict Canadian men.
- The incidence of prostate cancer is increasing due to the aging of the population.
- Over 90% of prostate cancer cases are curable if detected and treated in their earliest stages.
- The disease is a far greater threat for those with a family history of prostate cancer.
- The disease has no symptoms in its earliest, most curable stage – so if you are 40 years old, we recommend you talk to your doctor about a prostate examination, including a digital rectal exam (DRE) and a prostate specific antigen (PSA) blood test.
Prostate cancer is the most common non-skin malignancy in men
The Science and hope:
“There is ample evidence in the scientific literature that antagonists of Bradykini receptors such as R-954, (IntrakinTM), can be effective in the treatment of prostate cancer by inhibiting tumor cells’ growth and invasiveness. “
Other products in the pipeline:
Company is working on a cure for Neuropathy which until now is not stoppable or reversable. To give you an idea of how bad this is, 86,000 amputations are performed every year as a direct result of Diabetes and of that number, 25% will have the other limb amputated. We are talking about 150 Million people who have nerve damage of some kind which effects their ability to sleep, walk, drive a vehicle, and do just about any task that requires movement without pain. The largest drug companies in the world are working on this problem, and nothing is even close, until today. The company is working on not only a way to stop neuropathy in its path, but they are working on reversing neuropathy in patients.
The company also has a specialized water division that houses a state of the art bottling plant. What makes this product so unique is its blend of more oxygen and a technology that allows for your body to hold oxygen longer than any existing brand of oxygenated water, so it gives the consumer more of what they are looking for. It’s a superior product destined to dominate the marketplace. The product has show to increase Mental Alertness and concentration, physical performance, increase endurance, physical stamina helps prevents and alleviate chronic headaches and muscular cramps, improves sleeping, boosts your immune system and last but not least, gives you a younger and fresher appearance.
THE COMPANY:
The Company has the imagination, state of the state technology and products. All they need is capital. They are looking for $3.5 million for outside Office Expansion, Sales and Marketing, New Product Development and Operations. If you need additional information or have additional questions, email me back or call me at the number below and I will have the company forward you the information.
